The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland

AIMS: To evaluate the ability of first trimester plasma glycated CD59 (pGCD59) to predict gestational diabetes mellitus (GDM) at 24–28 weeks of gestation. METHODS: Prospectively, in 378 pregnant women, GDM was diagnosed using the one step 2 h 75 g oral glucose tolerance test adjudicated by the World...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdanet, Delia, Toth Castillo, Michelle, Doheny, Helen, Dervan, Louise, Angel Luque-Fernandez, Miguel, Halperin, Jose, O'Shea, Paula M., Dunne, Fidelma P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Scientific Publishers 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483034/
https://www.ncbi.nlm.nih.gov/pubmed/35907507
http://dx.doi.org/10.1016/j.diabres.2022.110023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483034/
https://www.ncbi.nlm.nih.gov/pubmed/35907507
http://dx.doi.org/10.1016/j.diabres.2022.110023

Ejemplares similares